TESTOSTERONE PROPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Testosterone Propionate patents expire, and when can generic versions of Testosterone Propionate launch?
Testosterone Propionate is a drug marketed by Bel Mar, Elkins Sinn, Lilly, and Watson Labs. and is included in eight NDAs.
The generic ingredient in TESTOSTERONE PROPIONATE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
Summary for TESTOSTERONE PROPIONATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 3 |
Patent Applications: | 3,977 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TESTOSTERONE PROPIONATE at DailyMed |
Recent Clinical Trials for TESTOSTERONE PROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas at Austin | Phase 4 |
University of Texas at Austin | N/A |
University of Vermont | Phase 1/Phase 2 |